Trukera Medical
its tear osmolarity system measures tear-film osmolarity as the reference biomarker for dry eye disease severity, with dynamic temperature-compensation technology documented in a dedicated patent and distributed in some markets through a Topcon Healthcare partnership.
- Country
- United States
Commercial
Tear osmolarity system
Coverage
| CN | EU | US | |
|---|---|---|---|
| diagnostics-medtech | ✓ | ✓ | ✓ |
Regulatorsfdaemanmpa
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Tear-fluid biopsy | diagnostics-medtech | Medium | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.